Mechanisms of action of immunopotentiating agents in cancer therapy.
D000818:Animals; D003911:Dextrans / Q000494:pharmacology; D004731:Endotoxins / Q000494:pharmacology; D056890:Eukaryota / Q000502:physiology; D006801:Humans; D007109:Immunity / Q000187:drug effects*; D007912:Lentinan / Q000494:pharmacology; D007978:Levamisole / Q000494:pharmacology; D009163:Mycobacterium bovis / Q000502:physiology; D009369:Neoplasms / Q000188:drug therapy*; D011119:Polynucleotides / Q000494:pharmacology; D011134:Polysaccharides / Q000494:pharmacology; D011425:Propionibacterium acnes / Q000502:physiology; D011714:Pyrans / Q000494:pharmacology; D012313:RNA / Q000494:pharmacology; D013268:Stimulation, Chemical; D013994:Tilorone / Q000494:pharmacology
D003911:Dextrans; D004731:Endotoxins; D011119:Polynucleotides; D011134:Polysaccharides; D011714:Pyrans; D007978:Levamisole; D007912:Lentinan; D012313:RNA; D013994:Tilorone